IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

300.50

Prev. Close

299.10

Turnover (lac.)

3,385

Day's High

302.00

Day's Low

292.70

52 Week's High

705.90

52 Week's Low

270.00

Book Value

431

Face Value

1

Mkt Cap (Cr.)

8,443

P/E

7.14

EPS

41.92

Divi. Yield

0.67

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd405.2044.4297,305.03763.370.683,020.4995.21
Dr Reddys Laboratories Ltd2,826.7031.2246,726.00548.100.712,497.60766.66
Divis Laboratories Ltd1,735.3534.6846,259.23267.350.921,139.92262.68
Cipla Ltd454.2516.6936,577.09694.000.663,126.21195.78
Lupin Ltd736.1519.9933,756.19445.930.672,878.91378.16

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Glenmark Pharmaceuticals Ltd is a research-driven, global, integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology. Its branded generics business has a significant... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by glenmark-pharmaceuticals-ltd

View

-

Reco. Price

0.00

Oct 23, 2019

Target Price

0.00

Target Returns:

0.00%

Result Express

Oct 23, 2019 06:32 PM

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    AGM

    Exp. Date

    27 Sep 2019

    Annc. Date

    26 Aug 2019

    AGM 27/09/2019We have to inform you that the 41st Annual General Meeting (AGM) of Members of the Com... More

  • Purpose

    Dividend

    Annc. Date

    29 May 2019

    Effective. Date

    19 Sep 2019

    Divi. Type

    Final

    Divi.(%)

    200

    Divi. Amt.

    2

    Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meet... More

  • Purpose

    Board Meeting

    Exp. Date

    13 Aug 2019

    Annc. Date

    31 Jul 2019

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More